Liu and co-authors [42] developed DTX-NLC functionalised with Flk-1 (A-3), a mouse monoclonal antibody with high affinity for tumours that overexpress vascular endothelial grow factor receptor 2 (VEGFR-2). The gene discussed is KDR; the disease is neoplasm.